期刊文献+

左氧氟沙星对糖尿病兔的致心律失常作用 被引量:2

Arrhythmogenic effect of levofloxacin in diabetic rabbits
原文传递
导出
摘要 目的 糖尿病患者QT间期延长反映了心脏的电不稳定性,这与心律失常的发生有关.作为临床常用的抗生素之一,左氧氟沙星可引起QT间期延长,甚至引起致命性尖端扭转性室性心动过速(Tdp).本研究旨在评估左氧氟沙星对糖尿病兔的致心律失常作用.方法 健康新西兰大白兔30只,体重2.0~2.5 kg,雌雄各半,应用随机数字法分为对照组(n=10)和实验组(n=20).实验组经耳缘静脉注射5%四氧嘧啶160 mg/kg建立糖尿病兔模型,对照组兔注射相同剂量的生理盐水.72 h后监测兔空腹血糖,若空腹血糖值大于基础血糖值的3倍,视为建模成功.饲养4周后制作冠状动脉灌流的左心室楔形心肌模型,分别灌注左氧氟沙星(1.14 mg/ml),比较灌注左氧氟沙星前后对照组兔和糖尿病兔跨壁心电图QT间期、左心室心肌内膜、外膜细胞的动作电位时限(APD)、跨壁复极离散度(TDR)及室性心律失常的发生率.结果 与对照组相比,糖尿病兔心肌QT间期延长19%,糖尿病内膜、外膜APD明显延长,跨壁复极离散度增大,早后除极发生率为36%,心室颤动(室颤)发生率18%.灌注左氧氟沙星后,对照组心肌QT间期、内膜、外膜APD均延长,跨壁复极离散度增大,早后除极发生率60%,所有心肌均未发生室颤;糖尿病组心肌QT间期、内膜、外膜APD、跨壁复极离散度均显著增大,早后除极的发生率为63%,心室颤动发生率为45%,室性心律失常发生率显著增加(P<0.05).结论 左氧氟沙星引起糖尿病兔QT间期延长,跨壁复极离散度异常增大.与对照组相比,糖尿病组灌注左氧氟沙星后更易发生心律失常. Objective The abnormal prolongation in QT interval in diabetics reflects the electric instability of heart,which is related to the incidence of cardiac arrhythmia.As one of the frequently used antibiotics in clinical practice,levofloxacin may prolong QT interval,or even lead to lethal ventricular arrhythmia-torsade de pointes(Tdp).The present study was to assess the arrhythmogenic effect of levofloxacinin on diabetic rabbits.Methods Thirty healthy New Zealand rabbits weighing 2.0-2.5 kg were randomized into the control group (n=10)and the test group(n =20).The rabbits in test group were injected with 5% tetraoxypyrimidine in a dosage of 160 mg/kg via the marginal vein to establish the diabetic rabbits model,while the control group was injected with the same volume of saline.The arterially perfused rabbit ventricular wedge preparations were produced four weeks later,which were infused with levofloxacin(1.14 mg/ml),and transmural ECG and action potential period from both endocardium(APDEndo)and epicardium(APDEpi)were simultaneously recorded and compared.Results The QT interval,APDEndo,APDEpi,,and transmural dispersion of repolarization(TDR) of diabetic rabbits were prolonged,the incidence rate of early after-depolarization(EAD) and ventricular fibrillation(VF) increased (P〈0.05).After perfusion with levofloxacin,the QT interval,APDEndo and APDEpi,TDR were longer,the incidence rate of EAD and VF were increased in test group(P〈0.05).Conclusion In comparison to the control group,ventricular arrhythmia is liable to be induced after levofloxacin perfusion in the diabetic group.
出处 《中华心律失常学杂志》 2014年第1期61-64,共4页 Chinese Journal of Cardiac Arrhythmias
基金 基金项目:浙江省自然科学基金(Y2110934)
关键词 左氧氟沙星 糖尿病兔 四氧嘧啶 跨壁复极离散度 室性心律失常 Levofloxacin Diabetic rabbits Tetraoxypyrimidine Transmural dispersion of repolarization Ventricular arrhythmia
  • 相关文献

参考文献13

  • 1Casis O, Echevarria E. Diabetic cardiomyopathy electromechanicalcellular alterations [ J ].Curr Vasc Pharmaco1,2004,2 : 237- 248.
  • 2Rossing P, Breum L, Major-Pedersen A, et al.Prolonged QTc inter- val predicts mortality in patients with Type 1 diabetes mellitus [ J], Diabet Med,2001,18 : 199- 205.
  • 3Frothingham R.Rates of torsades de pointes associated with cipro- floxacin, ofloxaein, levofloxaein, gatifloxaein, and moxifloxacin [ J ]. Pharmacotherapy ,2001,21 : 1468-1472.
  • 4孙文涛,雷春灵,赵四海,毕春潮,张璐.改良四氧嘧啶制作兔糖尿病模型的实验研究(英文)[J].国际眼科杂志,2010,10(10):1848-1850. 被引量:2
  • 5Yan GX, Shimizu W, Antzelevitch C. Characteristics and distribu- tion of M cells inarterially perfused canine left ventricular wedge preparations [ J ].Circulation, 1998,98 : 1921-1927.
  • 6Akita M, Shibazaki Y, Izumi M, et al. Comparative assessment of prurifloxacin, spariloxacin, gatifloxacin and levofioxacin in the rabbit model of proarrhythmia [ J ]. J Toxicol Sci, 2004,29 : 63-71.
  • 7Milberg P, Hilker E, Ramtin S, et al. Proarrhythmia as a class effect of quinolones : increased dispersion of repolarization and tri- angulation of action potential predict torsades de pointes [ J ]. J Cardiovasc Electrophysiol, 2007,18 : 647- 654.
  • 8Andemon ME, Mazur A, Yang T, et al.Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics [ J ].J Pharmacol Exp Ther,2001,296 : 806- 810.
  • 9Haverkamp W ,Breithardt G, Carom AJ, et al.The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs:clini- cal and regulatory implications. Report on a policy conference of the European Society of Cardiology [ J ]. Eur Heart J, 2000,21 : 1216-1231.
  • 10Kang J,Wang L,Chen XL,et al.Interactions of a series of fluoro- quinolone antibacterial drugs with the human cardiac K+ channel HERG[ J] .Mol Pharmaco1,2001,59:122-126.

二级参考文献2

共引文献1

同被引文献24

  • 1柴栋,王睿.氟喹诺酮类抗菌药物所致心肌传导紊乱[J].中国药物应用与监测,2005,2(5):12-14. 被引量:5
  • 2Maahs D M, Dabelea D, D'Agostino R B Jr, et al. Glucose control predicts 2-year change in lipid profile in youth with type 1 dia- betes[J]. J Pediatr,2013,162(1):101-107.
  • 3Maahs D M, Wadwa R P, Bishop F, et al. Dyslipidemia in youth with diabetes: to treat or not to treat[J].? J Pediatr, 2008, 153(4):458- 465.
  • 4Renard C B, Kramer F, Johansson F, et al. Diabetes and dia- betes-associated lipid abnormalities have distinct effects on initi- ation and progression of atherosclerotic lesions[J]. J Clin Invest, 2004,114(5):659-668.
  • 5Johansson F, Kramer F, Barnhart S, et al. Type 1 diabetes pro- motes disruption of advanced atherosclerotic lesions in LDL-C receptor-deficient mice[J]. Proc Natl Acad Sci U S A, 2008, 105 (6):2082-2087.
  • 6The Diabetes Control and Complications Trial Research Group. The effects of intensive treatment of diabetes on the development and progression of long-term complications of insulin-depen-dent diabetes mellitus[J]. N Engl J Med, 1993, 329(14):977-986.
  • 7The Diabetes Control and Complications Trial (DCCT) Research Group. Effect of intensive diabetes management on macrovascu- lar events and risk factors in the diabetes control and complica- tions trial[J]. Am J Cardiol,1995,75:894-903.
  • 8Maahs D M, Ogden L G, Dabelea D, et al. Association of gly- caemia with lipids in adults with type 1 diabetes: modification by dyslipidaemia medication[J]. Diabetologia, 2010, 53(12): 2518- 2525.
  • 9de Boer I H, Kestenbaum B, Rue T C, et al. Insulin therapy, hyper- glycemia, and hypertension in type 1 diabetes mellitus[J]. Arch Intern Med, 2008,168:1867-1873.
  • 10Nathan D M, Cleary P A, Backlund J Y, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 dia- betes[J]. N Engl J Med,2005,353:2643-2653.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部